Listed

Grace Therapeutics, Inc.

GRCENasdaqCIK 1444192HealthcareFiscal year ends Mar 31

Reports and events: 372 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Grace Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2021-08-1210:57 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-21-005872
2021-08-1210:56 ET10-QQuarterly reportPeriod 2021-06-300001171843-21-005871
2021-07-2308:43 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-21-005045
2021-07-2117:17 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-21-004979
2021-06-2207:00 ET10-KAnnual reportPeriod 2021-03-310001171843-21-004462
2021-06-2207:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-21-004460
2021-05-1707:11 ET8-K3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-21-003558
2021-05-0707:09 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-21-003288
2021-03-0917:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-21-001601
2021-02-0916:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-21-000882
2021-02-0907:00 ET10-QQuarterly reportPeriod 2020-12-310001171843-21-000849
2021-01-2707:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-21-000518
2020-12-0408:00 ET8-K8.01 Other events0001171843-20-008355
2020-11-1607:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-20-008003
2020-11-1607:00 ET10-QQuarterly reportPeriod 2020-09-300001171843-20-008002
2020-10-0707:30 ET8-K3.01 Delisting notice0001171843-20-006922
2020-10-0215:39 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-20-006824
2020-09-2908:19 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-20-006713
2020-09-1821:54 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001171843-20-006507
2020-09-1107:00 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-20-006409
2020-09-0916:00 ETDEF 14AProxy statementPeriod 2020-09-300001171843-20-006363
2020-08-3116:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-20-006188
2020-08-1308:30 ET10-QQuarterly reportPeriod 2020-06-300001171843-20-005901
2020-08-1308:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-20-005899
2020-07-3116:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001171843-20-005439
2020-06-3009:01 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001171843-20-004630
2020-06-2916:02 ET10-KAnnual reportPeriod 2020-03-310001171843-20-004613
2020-06-2912:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-20-004607
2020-06-1909:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-20-004446
2020-04-3016:22 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001171843-20-003135
2020-04-2016:05 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-20-002717
2020-04-0117:12 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001171843-20-002270
2020-03-1108:00 ET6-KReport of a foreign private issuerPeriod 2020-03-110001171843-20-001625
2020-02-2817:00 ET6-KReport of a foreign private issuerPeriod 2020-02-280001171843-20-001384
2020-02-1408:00 ET6-KReport of a foreign private issuerPeriod 2020-02-140001171843-20-000982
2020-02-1408:00 ET6-KReport of a foreign private issuerPeriod 2020-02-130001171843-20-000981
2020-02-1309:00 ET6-KReport of a foreign private issuerPeriod 2020-02-130001171843-20-000950
2020-02-1007:00 ET6-KReport of a foreign private issuerPeriod 2020-02-100001171843-20-000806
2020-01-1306:21 ET6-KReport of a foreign private issuerPeriod 2020-01-130001171843-20-000177
2019-12-2420:43 ET6-KReport of a foreign private issuerPeriod 2019-12-230001171843-19-008308
2019-11-2607:58 ET6-KReport of a foreign private issuerPeriod 2019-11-260001171843-19-007828
2019-11-1808:46 ET6-KReport of a foreign private issuerPeriod 2019-11-180001171843-19-007619
2019-11-1307:55 ET6-KReport of a foreign private issuerPeriod 2019-09-300001171843-19-007485
2019-11-1307:55 ET6-KReport of a foreign private issuerPeriod 2019-11-130001171843-19-007484
2019-11-0708:42 ET6-KReport of a foreign private issuerPeriod 2019-11-070001171843-19-007299
2019-11-0609:39 ET6-KReport of a foreign private issuerPeriod 2019-11-060001171843-19-007218
2019-11-0409:24 ET6-KReport of a foreign private issuerPeriod 2019-11-040001171843-19-007107
2019-10-0109:00 ET6-KReport of a foreign private issuerPeriod 2019-10-010001171843-19-006227
2019-09-3008:37 ET6-KReport of a foreign private issuerPeriod 2019-09-300001171843-19-006188
2019-09-0908:41 ET6-KReport of a foreign private issuerPeriod 2019-09-090001171843-19-005862

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:10 ET. Listed shows no prices and gives no investment advice.